China · Delayed Price · Currency is CNY Heren Health Statistics
Total Valuation
Heren Health has a market cap or net worth of CNY 3.66 billion. The enterprise value is 3.25 billion.
| Market Cap | 3.66B |
| Enterprise Value | 3.25B |
Important Dates
The next confirmed earnings date is Saturday, October 24, 2026.
| Earnings Date | Oct 24, 2026 |
| Ex-Dividend Date | Jun 15, 2026 |
Share Statistics
Heren Health has 262.56 million shares outstanding. The number of shares has decreased by -25.18% in one year.
| Current Share Class | 262.56M |
| Shares Outstanding | 262.56M |
| Shares Change (YoY) | -25.18% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 15.73% |
| Float | 145.84M |
Valuation Ratios
The trailing PE ratio is 157.05.
| PE Ratio | 157.05 |
| Forward PE | n/a |
| PS Ratio | 8.44 |
| PB Ratio | 3.21 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | 46.43 |
| P/OCF Ratio | 30.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 125.19, with an EV/FCF ratio of 41.15.
| EV / Earnings | 165.77 |
| EV / Sales | 7.48 |
| EV / EBITDA | 125.19 |
| EV / EBIT | 158.49 |
| EV / FCF | 41.15 |
Financial Position
The company has a current ratio of 4.15, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.15 |
| Quick Ratio | 3.94 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.03 |
| Interest Coverage | 13.29 |
Financial Efficiency
Return on equity (ROE) is 2.09% and return on invested capital (ROIC) is 2.91%.
| Return on Equity (ROE) | 2.09% |
| Return on Assets (ROA) | 0.90% |
| Return on Invested Capital (ROIC) | 2.91% |
| Return on Capital Employed (ROCE) | 1.79% |
| Weighted Average Cost of Capital (WACC) | 7.14% |
| Revenue Per Employee | 546,448 |
| Profits Per Employee | 24,665 |
| Employee Count | 794 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 7.24 |
Taxes
In the past 12 months, Heren Health has paid 302,220 in taxes.
| Income Tax | 302,220 |
| Effective Tax Rate | 1.27% |
Stock Price Statistics
The stock price has increased by +13.42% in the last 52 weeks. The beta is 0.52, so Heren Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +13.42% |
| 50-Day Moving Average | 12.69 |
| 200-Day Moving Average | 13.33 |
| Relative Strength Index (RSI) | 54.46 |
| Average Volume (20 Days) | 5,392,719 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Heren Health had revenue of CNY 433.88 million and earned 19.58 million in profits. Earnings per share was 0.09.
| Revenue | 433.88M |
| Gross Profit | 179.81M |
| Operating Income | 20.48M |
| Pretax Income | 23.83M |
| Net Income | 19.58M |
| EBITDA | 24.75M |
| EBIT | 20.48M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 448.39 million in cash and 1.98 million in debt, with a net cash position of 446.42 million or 1.70 per share.
| Cash & Cash Equivalents | 448.39M |
| Total Debt | 1.98M |
| Net Cash | 446.42M |
| Net Cash Per Share | 1.70 |
| Equity (Book Value) | 1.14B |
| Book Value Per Share | 4.24 |
| Working Capital | 842.07M |
Cash Flow
In the last 12 months, operating cash flow was 120.44 million and capital expenditures -41.55 million, giving a free cash flow of 78.89 million.
| Operating Cash Flow | 120.44M |
| Capital Expenditures | -41.55M |
| Depreciation & Amortization | 4.26M |
| Net Borrowing | -70.80M |
| Free Cash Flow | 78.89M |
| FCF Per Share | 0.30 |
Margins
Gross margin is 41.44%, with operating and profit margins of 4.72% and 4.51%.
| Gross Margin | 41.44% |
| Operating Margin | 4.72% |
| Pretax Margin | 5.49% |
| Profit Margin | 4.51% |
| EBITDA Margin | 5.70% |
| EBIT Margin | 4.72% |
| FCF Margin | 18.18% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 0.22%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 0.22% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 46.13% |
| FCF Payout Ratio | 9.99% |
| Buyback Yield | 25.18% |
| Shareholder Yield | 25.39% |
| Earnings Yield | 0.53% |
| FCF Yield | 2.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 16, 2021. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 16, 2021 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Heren Health has an Altman Z-Score of 9.18 and a Piotroski F-Score of 6.
| Altman Z-Score | 9.18 |
| Piotroski F-Score | 6 |